The global ovarian cancer market is experiencing a transformative phase, driven by significant advancements in diagnostic technologies, therapeutic innovations, and a heightened focus on personalized medicine. As the incidence of ovarian cancer continues to rise, the demand for effective treatment options and early detection methods is propelling market growth across various regions....